See more : Toppan Inc. (TONPF) Income Statement Analysis – Financial Results
Complete financial analysis of Health & Life Co., Ltd. (1781.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Health & Life Co., Ltd., a leading company in the Healthcare industry within the Healthcare sector.
- Solstice Minerals Limited (SLS.AX) Income Statement Analysis – Financial Results
- QS Energy, Inc. (QSEP) Income Statement Analysis – Financial Results
- Sunrise Communications AG (SNREV) Income Statement Analysis – Financial Results
- Ross Acquisition Corp II WT (ROSS-WT) Income Statement Analysis – Financial Results
- IVF Hartmann Holding AG (VBSN.SW) Income Statement Analysis – Financial Results
Health & Life Co., Ltd. (1781.TWO)
About Health & Life Co., Ltd.
Health & Life Co., Ltd. manufactures and sells products for cardiovascular disease, in-vitro diagnostics, and respiratory care worldwide. It offers vibrating mesh nebulizers, blood pressure monitor products, IR thermometers, and hearing aid devices. The company was founded in 1996 and is based in New Taipei City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 601.17M | 797.54M | 811.88M | 774.16M | 421.16M |
| Cost of Revenue | 508.07M | 699.82M | 766.12M | 647.09M | 375.44M |
| Gross Profit | 93.11M | 97.73M | 45.76M | 127.06M | 45.73M |
| Gross Profit Ratio | 15.49% | 12.25% | 5.64% | 16.41% | 10.86% |
| Research & Development | 16.16M | 17.34M | 22.81M | 21.33M | 19.79M |
| General & Administrative | 96.80M | 101.35M | 92.55M | 97.17M | 87.07M |
| Selling & Marketing | 20.15M | 24.12M | 27.29M | 25.32M | 16.56M |
| SG&A | 116.95M | 125.47M | 119.84M | 122.49M | 104.30M |
| Other Expenses | 0.00 | 31.28M | 14.72M | 283.45M | 0.00 |
| Operating Expenses | 134.17M | 142.81M | 142.66M | 143.81M | 124.09M |
| Cost & Expenses | 642.23M | 842.62M | 908.77M | 790.90M | 499.53M |
| Interest Income | 2.26M | 775.00K | 1.95M | 980.00K | 787.00K |
| Interest Expense | 5.27M | 3.14M | 3.08M | 3.13M | 4.05M |
| Depreciation & Amortization | 24.44M | 24.18M | 17.17M | 11.87M | 15.28M |
| EBITDA | -7.95M | 11.85M | -65.47M | 278.30M | -56.74M |
| EBITDA Ratio | -1.32% | 1.40% | -7.77% | 36.11% | -14.98% |
| Operating Income | -41.06M | -13.02M | -80.22M | 267.68M | -78.36M |
| Operating Income Ratio | -6.83% | -1.63% | -9.88% | 34.58% | -18.61% |
| Total Other Income/Expenses | 3.50M | -2.44M | 13.59M | 281.29M | 3.39M |
| Income Before Tax | -37.56M | -15.47M | -83.30M | 264.52M | -74.97M |
| Income Before Tax Ratio | -6.25% | -1.94% | -10.26% | 34.17% | -17.80% |
| Income Tax Expense | -4.33M | 2.08M | -20.96M | 58.54M | 1.47M |
| Net Income | -33.23M | -17.55M | -62.34M | 205.98M | -76.44M |
| Net Income Ratio | -5.53% | -2.20% | -7.68% | 26.61% | -18.15% |
| EPS | -0.70 | -0.37 | -1.31 | 4.34 | -1.61 |
| EPS Diluted | -0.70 | -0.37 | -1.31 | 4.34 | -1.61 |
| Weighted Avg Shares Out | 47.41M | 47.41M | 47.41M | 47.41M | 47.41M |
| Weighted Avg Shares Out (Dil) | 47.41M | 47.41M | 47.41M | 47.51M | 47.41M |
Source: https://incomestatements.info
Category: Stock Reports